Skip to main content
Top
Published in: Journal of Nephrology 7/2023

28-09-2023 | Diuretics | original Article

Loop diuretics improve conditions of dialysis inception in advanced CKD: an observational cohort study

Authors: Dogan-Firat Bozman, Dorothée Bazin, Frédéric Lavainne, Aghiles Hamroun, Cécile Couchoud, Thierry Hannedouche, on the REIN registry

Published in: Journal of Nephrology | Issue 7/2023

Login to get access

Abstract

Background

Diuretics can reduce fluid overload but their effects on conditions of dialysis start remain elusive. We aimed to determine whether loop diuretics exposure in the year before inception can delay the need for dialysis, affect the conditions of dialysis start, and cause early mortality three months after initiation in pre-dialysis patients.

Methods

All adult patients starting dialysis from 2009 to 2015 in the REIN registry were included. Three subgroups were defined according to diuretics exposure: “continuous”, “stopped”, or “no diuretics” over the year before inception and compared for pre-dialysis hospitalization rates, and 3-month mortality after dialysis.

Results

Among 59,302 patients, we found fewer emergency initiations of dialysis in the continuous diuretics group than in the stopped diuretics and no diuretics groups: 9492 (27.5%) vs 1905 (32.3%) and 5226 (35.0%), respectively; p < 0.0001. In the continuous diuretics group, there were fewer starts on central venous catheters than in the stopped diuretics and no diuretics groups: 16,677 (49.4%) vs. 3246 (56.0%) vs. 8,639 (58.4%); p < 0.0001. Patients with continuous diuretic exposure had a lower hospitalization rate than the stopped diuretics group in the year prior to dialysis, except for heart failure. The unadjusted 3-month hazard ratio of mortality after dialysis inception was significantly higher in the “no diuretics” or “stopped diuretics” groups compared with “continuous diuretics”, but the excess of risk was blunted after adjustment for emergency start and pre-dialysis visits to a nephrologist.

Conclusion

Continuous loop diuretics exposure in the year before dialysis was associated with better conditions of dialysis inception, and possibly lower mortality rates in the three months after inception.

Graphical abstract

Appendix
Available only for authorised users
Literature
1.
go back to reference Chen SC, Su HM, Hung CC, Chang JM, Liu WC, Tsai JC, Lin MY, Hwang SJ, Chen HC (2011) Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 6(12):2750–2758CrossRefPubMedPubMedCentral Chen SC, Su HM, Hung CC, Chang JM, Liu WC, Tsai JC, Lin MY, Hwang SJ, Chen HC (2011) Echocardiographic parameters are independently associated with rate of renal function decline and progression to dialysis in patients with chronic kidney disease. Clin J Am Soc Nephrol 6(12):2750–2758CrossRefPubMedPubMedCentral
2.
go back to reference Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA (2011) Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis 58(5):717–728CrossRefPubMed Desai AS, Toto R, Jarolim P, Uno H, Eckardt KU, Kewalramani R, Levey AS, Lewis EF, McMurray JJ, Parving HH, Solomon SD, Pfeffer MA (2011) Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis 58(5):717–728CrossRefPubMed
3.
go back to reference Tsai YC, Chiu YW, Tsai JC, Kuo HT, Hung CC, Hwang SJ, Chen TH, Kuo MC, Chen HC (2015) Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Clin J Am Soc Nephrol 10(1):39–46CrossRefPubMed Tsai YC, Chiu YW, Tsai JC, Kuo HT, Hung CC, Hwang SJ, Chen TH, Kuo MC, Chen HC (2015) Association of fluid overload with cardiovascular morbidity and all-cause mortality in stages 4 and 5 CKD. Clin J Am Soc Nephrol 10(1):39–46CrossRefPubMed
4.
go back to reference Tsai YC, Tsai JC, Chiu YW, Kuo HT, Chen SC, Hwang SJ, Chen TH, Kuo MC, Chen HC (2013) Is fluid overload more important than diabetes in renal progression in late chronic kidney disease? PLoS ONE 8(12):e82566CrossRefPubMedPubMedCentral Tsai YC, Tsai JC, Chiu YW, Kuo HT, Chen SC, Hwang SJ, Chen TH, Kuo MC, Chen HC (2013) Is fluid overload more important than diabetes in renal progression in late chronic kidney disease? PLoS ONE 8(12):e82566CrossRefPubMedPubMedCentral
5.
go back to reference Tsai YC, Tsai JC, Chen SC, Chiu YW, Hwang SJ, Hung CC, Chen TH, Kuo MC, Chen HC (2014) Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis 63(1):68–75CrossRefPubMed Tsai YC, Tsai JC, Chen SC, Chiu YW, Hwang SJ, Hung CC, Chen TH, Kuo MC, Chen HC (2014) Association of fluid overload with kidney disease progression in advanced CKD: a prospective cohort study. Am J Kidney Dis 63(1):68–75CrossRefPubMed
6.
go back to reference Sun L, Li Q, Sun Z, Duan S, Nie G, Dong J, Zhang C, Zeng M, Sun B, Yuan Y, Wang N, Mao H, Xing C, Zhang B (2022) Impact of overhydration on left ventricular hypertrophy in patients with chronic kidney disease. Front Nutr 9:761848CrossRefPubMedPubMedCentral Sun L, Li Q, Sun Z, Duan S, Nie G, Dong J, Zhang C, Zeng M, Sun B, Yuan Y, Wang N, Mao H, Xing C, Zhang B (2022) Impact of overhydration on left ventricular hypertrophy in patients with chronic kidney disease. Front Nutr 9:761848CrossRefPubMedPubMedCentral
7.
go back to reference Hung SC, Lai YS, Kuo KL, Tarng DC (2015) Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc 4(5):e001918CrossRefPubMedPubMedCentral Hung SC, Lai YS, Kuo KL, Tarng DC (2015) Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc 4(5):e001918CrossRefPubMedPubMedCentral
8.
go back to reference Esmeray K, Dizdar OS, Erdem S, Gunal Aİ (2018) Effect of strict volume control on renal progression and mortality in non-dialysis-dependent chronic kidney disease patients: a prospective interventional study. Med Princ Pract 27(5):420–427CrossRefPubMedPubMedCentral Esmeray K, Dizdar OS, Erdem S, Gunal Aİ (2018) Effect of strict volume control on renal progression and mortality in non-dialysis-dependent chronic kidney disease patients: a prospective interventional study. Med Princ Pract 27(5):420–427CrossRefPubMedPubMedCentral
9.
go back to reference Rivara MB, Chen CH, Nair A, Cobb D, Himmelfarb J, Mehrotra R (2017) Indication for dialysis initiation and mortality in patients with chronic kidney failure: a retrospective cohort study. Am J Kidney Dis 69(1):41–50CrossRefPubMedPubMedCentral Rivara MB, Chen CH, Nair A, Cobb D, Himmelfarb J, Mehrotra R (2017) Indication for dialysis initiation and mortality in patients with chronic kidney failure: a retrospective cohort study. Am J Kidney Dis 69(1):41–50CrossRefPubMedPubMedCentral
10.
go back to reference Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2016) Chronic kidney disease, fluid overload and diuretics: a complicated triangle. PLoS ONE 11(7):e0159335CrossRefPubMedPubMedCentral Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2016) Chronic kidney disease, fluid overload and diuretics: a complicated triangle. PLoS ONE 11(7):e0159335CrossRefPubMedPubMedCentral
11.
go back to reference Verbrugge FH, Martens P, Testani JM, Tang WHW, Kuypers D, Bammens B (2020) Measures of loop diuretic efficiency and prognosis in chronic kidney disease. Cardiorenal Med 10(6):402–414CrossRefPubMed Verbrugge FH, Martens P, Testani JM, Tang WHW, Kuypers D, Bammens B (2020) Measures of loop diuretic efficiency and prognosis in chronic kidney disease. Cardiorenal Med 10(6):402–414CrossRefPubMed
12.
go back to reference Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2017) Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center. Clin Exp Nephrol 21(6):1011–1023CrossRefPubMed Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2017) Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center. Clin Exp Nephrol 21(6):1011–1023CrossRefPubMed
13.
go back to reference Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2017) Diuretics prescribing in chronic kidney disease patients: physician assessment versus bioimpedence spectroscopy. Clin Exp Nephrol 21(3):488–496CrossRefPubMed Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH (2017) Diuretics prescribing in chronic kidney disease patients: physician assessment versus bioimpedence spectroscopy. Clin Exp Nephrol 21(3):488–496CrossRefPubMed
14.
go back to reference Raffray M, Bayat S, Lassalle M, Couchoud C (2020) Linking disease registries and nationwide healthcare administrative databases: the French renal epidemiology and information network (REIN) insight. BMC Nephrol 21(1):25CrossRefPubMedPubMedCentral Raffray M, Bayat S, Lassalle M, Couchoud C (2020) Linking disease registries and nationwide healthcare administrative databases: the French renal epidemiology and information network (REIN) insight. BMC Nephrol 21(1):25CrossRefPubMedPubMedCentral
16.
go back to reference Lassalle M, Monnet E, Ayav C et al (2019) 2017 Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry. Transpl Int 32(9):892–902CrossRefPubMed Lassalle M, Monnet E, Ayav C et al (2019) 2017 Annual Report Digest of the Renal Epidemiology Information Network (REIN) registry. Transpl Int 32(9):892–902CrossRefPubMed
17.
go back to reference Palmer BF, Clegg DJ (2020) Fluid overload as a therapeutic target for the preservative management of chronic kidney disease. Curr Opin Nephrol Hypertens 29(1):22–28CrossRefPubMed Palmer BF, Clegg DJ (2020) Fluid overload as a therapeutic target for the preservative management of chronic kidney disease. Curr Opin Nephrol Hypertens 29(1):22–28CrossRefPubMed
19.
go back to reference Smart NA, Dieberg G, Ladhani M, Titus T (2014) Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. juin 6:CD007333 Smart NA, Dieberg G, Ladhani M, Titus T (2014) Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease. Cochrane Database Syst Rev. juin 6:CD007333
20.
go back to reference Zamboli P, De Nicola L, Minutolo R, Chiodini P, Crivaro M, Tassinario S et al (2011) Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial. Nephrol Dial Transplant 26(5):1575–1583CrossRefPubMed Zamboli P, De Nicola L, Minutolo R, Chiodini P, Crivaro M, Tassinario S et al (2011) Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial. Nephrol Dial Transplant 26(5):1575–1583CrossRefPubMed
21.
go back to reference Prisant LM, Kleinman DJ, Carr AA, Bottini PB, Gross CM (1994) Assessment of echocardiographic left ventricular mass before and after acute volume depletion. Am J Hypertens 7(5):425–428CrossRefPubMed Prisant LM, Kleinman DJ, Carr AA, Bottini PB, Gross CM (1994) Assessment of echocardiographic left ventricular mass before and after acute volume depletion. Am J Hypertens 7(5):425–428CrossRefPubMed
22.
go back to reference Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5(12):2024–2031 (62)CrossRefPubMed Foley RN, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barré PE (1995) The prognostic importance of left ventricular geometry in uremic cardiomyopathy. J Am Soc Nephrol 5(12):2024–2031 (62)CrossRefPubMed
23.
go back to reference Tripepi G, Pannier B, D’Arrigo G, Mallamaci F, Zoccali C, London G (2017) Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure. Kidney Int 91(3):704–710CrossRefPubMed Tripepi G, Pannier B, D’Arrigo G, Mallamaci F, Zoccali C, London G (2017) Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure. Kidney Int 91(3):704–710CrossRefPubMed
24.
go back to reference Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L et al (2013) Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. Int J Clin Pract 67(7):656–664CrossRefPubMed Dini FL, Ghio S, Klersy C, Rossi A, Simioniuc A, Scelsi L et al (2013) Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. Int J Clin Pract 67(7):656–664CrossRefPubMed
Metadata
Title
Loop diuretics improve conditions of dialysis inception in advanced CKD: an observational cohort study
Authors
Dogan-Firat Bozman
Dorothée Bazin
Frédéric Lavainne
Aghiles Hamroun
Cécile Couchoud
Thierry Hannedouche
on the REIN registry
Publication date
28-09-2023
Publisher
Springer International Publishing
Published in
Journal of Nephrology / Issue 7/2023
Print ISSN: 1121-8428
Electronic ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-023-01752-3

Other articles of this Issue 7/2023

Journal of Nephrology 7/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.